- ►pubget.com [PDF] T Walsh, S Casadei, KH Coats, E Swisher, SM … - Jama, 2006 - Am Med Assoc Context Genetic testing for inherited mutations in BRCA1 and BRCA2 has become
integral to the care of women with a severe family history of breast or ovarian
cancer, but an unknown number of patients receive negative (ie, wild-type) ... Cited by 195 - Related articles - BL Direct - All 7 versions
DH Roukos, S Murray, E Briasoulis - CANCER BIOLOGY AND THERAPY, 2007 - gastricbreastcancer.com 1Surgical Oncology Research Unit, Department of Surgery; 3Department of Medical
Oncology; Ioannina University School of Medicine; Ioannina, Greece 2Department
of Molecular Biology and Genetics, Metropolitan Hospital; Athens, Greece * ... Cited by 63 - Related articles - View as HTML - BL Direct - All 5 versions
- ►cdc.gov [PDF] MJ Khoury, M Gwinn, PW Yoon, N Dowling, CA … - Genetics in Medicine, 2007 - pdfs.journals.lww.com Advances in genomics have led to mounting expectations in regard to their impact
on health care and disease prevention. In light of this fact, a comprehensive
research agenda is needed to move human genome discoveries into health ... Cited by 64 - Related articles - BL Direct - All 13 versions
DH Roukos, E Briasoulis - Nature Clinical Practice Oncology, 2007 - medscape.com Life-saving, risk-reducing medical interventions are required for women with a
BRCA1/2 mutation. Interventions comprise a four-stage approach that involves
risk assessment, genetic counseling, gene-mutation analysis and medical ... Cited by 61 - Related articles - BL Direct - All 5 versions
- ►casemedicine.com [PDF] - Free from Publisher A Qaseem, V Snow, K Sherif, M Aronson, KB … - Annals of Internal Medicine, 2007 - Am Coll Physicians *This paper, written by Amir Qaseem, MD, PhD, MHA; Vincenza Snow, MD; Katherine
Sherif, MD; Mark Aronson, MD; Kevin B. Weiss, MD, MPH; and Douglas K. Owens, MD,
MS, was developed for the Clinical Efficacy Assessment Subcommittee of the ... Cited by 39 - Related articles - All 10 versions
VÜ Onay, L Briollais, JA Knight, E Shi, Y Wang … - BMC cancer, 2006 - biomedcentral.com In an attempt to identify the breast cancer risk conferred by SNP interactions,
we have studied 19 SNPs from genes involved in major cancer related pathways.
All SNPs were genotyped by TaqMan 5'nuclease assay. The association between ... Cited by 37 - Related articles - Cached - All 6 versions
W Burke, MJ Khoury, A Stewart, RL Zimmern - Genetics in Medicine, 2006 - journals.lww.com The health benefits of the Human Genome Project have been widely anticipated.
Experts predict a new era of individ- ualized disease prevention based on
testing for genetic susceptibilities,1 and safer, more effective use of ... Cited by 34 - Related articles - BL Direct - All 4 versions
MJ Bermejo-Perez, S Marquez-Calderon, A … - International Journal of Cancer, 2007 - interscience.wiley.com A systematic review of the literature was conducted to assess the outcomes of
preventive interventions (prophylactic surgery, intensive cancer screening, and
chemoprevention) in women who carry mutations in BRCA1/2 genes, in terms of ... Cited by 26 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] G Parmigiani, S Chen, ES Iversen Jr, TM … - Annals of internal medicine, 2007 - Am Coll Physicians Giovanni Parmigiani, PhD; Sining Chen, PhD; Edwin S. Iversen Jr., PhD; Tara M.
Friebel, MPH; Dianne M. Finkelstein, PhD; Hoda Anton-Culver, PhD; Argyrios
Ziogas, PhD; Barbara L. Weber, MD; Andrea Eisen, MD; Kathleen E. Malone, ... Cited by 26 - Related articles - BL Direct - All 8 versions
JT Heshka, C Palleschi, H Howley, B Wilson, … - Genetics in Medicine, 2008 - journals.lww.com Genetic testing may enable early disease detection, targeted surveillance, and
result in effective prevention strategies. Knowledge of genetic risk may also
enable behavioral change. However, the impact of carrier status from the ... Cited by 21 - Related articles - BL Direct - All 4 versions
